FrancophonIA/ELRC3.0 huggingface dataset:
English: Following the administration of 24 mg/m² (up to a maximum of 40 mg) subcutaneously every other week to patients with polyarticular juvenile idiopathic arthritis (JIA) who were 4 to 17 years the mean trough steadystate (values measured from week 20 to 48) serum adalimumab concentration was 5.6 ± 5.6 μg/mL (102 % CV) for adalimumab without concomitant methotrexate and 10.9 ± 5.2 μg/mL (47.7 % CV) with
Danish: 2 (op til et maksimum på 40 mg) subkutant hver anden uge til patienter med polyartikulær juvenil idiopatisk artrit (JIA), som var 4 til 17 år, var den gennemsnitlige dalserumkoncentration af adalimumab ved steady state (værdier målt fra uge 20 til 48) 5,6 ± 5,6 µg/ml (102 % CV) for adalimumab uden samtidig methotrexat og 10,9 ± 5,2 µg/ml (47,7 % CV) med
English: You should not take Cyltezo with medicines containing the active substances anakinra or abatacept due to increased risk of serious infection.
Danish: På grund af øget risiko for alvorlig infektion, bør du ikke tage Cyltezo sammen med medicin, der indeholder de aktive stoffer anakinra eller abatacept.
English: Adults with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or axial spondyloarthritis without radiographic evidence of ankylosing spondylitis The usual dose for adults with rheumatoid arthritis, ankylosing spondylitis, axial spondyloarthritis without radiographic evidence of ankylosing spondylitis and for patients with psoriatic arthritis is 40 mg adalimumab given every other week as a single dose.
Danish: Den sædvanlige dosis til voksne med reumatoid artrit, ankyloserende spondylitis, aksial spondyloartritis uden radiografiske tegn på ankyloserende spondylitis og til patienter med psoriasisartrit er 40 mg adalimumab hver anden uge som enkeltdosis.
English: In the open-label extension of RA study V, the mean change from baseline at Year 10 in the modified Total Sharp Score was 10.8, 9.2 and 3.9 in patients originally randomised to methotrexate monotherapy, adalimumab monotherapy and adalimumab/methotrexate combination therapy, respectively.
Danish: I den åbne forlængelse af RA-studie V hos patienter oprindeligt randomiseret til henholdsvis methotrexat-monoterapi, adalimumab-monoterapi eller kombinationsbehandling med adalimumab og methotrexat, var den gennemsnitlige ændring fra baseline ved år 10 i modificeret Total Sharp Score 10,8, 9,2 og 3,9.
English: • It is important that you tell your baby's doctors and other health care professionals about your Cyltezo use during your pregnancy before the baby receives any vaccine.
Danish: • Det er vigtigt, at du fortæller barnets læge og andre sundhedspersoner, at du fik Cyltezo under graviditeten, før dit barn får nogen vaccinationer (for mere information om vacciner, se afsnittet vedrørende ”Advarsler og forsigtighedsregler”).
English: Ophthalmologists are advised to consult with an appropriate specialist before initiation of treatment with Cyltezo (see section 4.4).
Danish: Før initiering af behandling med Cyltezo rådes øjenlæger til at rådføre sig med en passende specialist (se pkt.
English: All subjects received open-label induction therapy at a dose based on their Baseline body weight: 160 mg at week 0 and 80 mg at week 2 for subjects ≥ 40 kg, and 80 mg and 40 mg, respectively, for subjects < 40 kg.
Danish: Alle patienter fik åben induktionsbehandling med doser baseret på deres baseline-legemsvægt: henholdsvis 160 mg i uge 0 og 80 mg i uge 2 til patienter ≥ 40 kg og 80 mg henholdsvis 40 mg til
English: Erythema multiforme Stevens-Johnson syndrome angioedema cutaneous vasculitis lichenoid skin reaction
Danish: , Stevens-Johnsons syndrom angioødem
English: The reported rates for non-melanoma skin cancers and lymphomas are approximately 0.2 and 0.3 per 1,000 patient treatment years, respectively (see section 4.4).
Danish: Den rapporterede hyppighed af ikke- melanom hudkræft og lymfomer er henholdsvis cirka 0,2 og 0,3 pr. 1.000 patient
English: o Expiration date on pre-filled syringe or carton has passed o Medication is cloudy, discolored, frozen, or contains flakes or particles o Pre-filled syringe appears cracked, damaged, or leaking o Pre-filled syringe has already been used o Pre-filled syringe has been left in direct light
Danish: • Brug IKKE den fyldte injektionssprøjte, hvis: ○ udløbsdatoen angivet på den fyldte injektionssprøjte eller på kartonen er overskredet ○ lægemidlet er uklart, misfarvet, frossent eller indeholder flager eller partikler ○ den fyldte injektionssprøjte ser revnet eller beskadiget ud, eller den lækker ○ den fyldte injektionssprøjte allerede er blevet brugt ○ den fyldte injektionssprøjte er blevet efterladt i direkte lys.
English: The inner part of the cap of the syringe (the needle cover) contains natural rubber (latex).
Danish: Den indre del af hætten på injektionssprøjten (beskyttelseshætten) indeholder naturgummi (latex).
English: Upon completion of the first 104 weeks, 497 patients enrolled in an open-label extension phase in which 40 mg of adalimumab was administered
Danish: Efter at have gennemført de første 104 uger blev 497 patienter optaget i et åbent forlængelsesstudie, hvor 40 mg adalimumab blev administreret hver anden uge i op til 10 år.
English: Cyltezo is indicated for treatment of moderately to severely active Crohn's disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.
Danish: Cyltezo er indiceret til behandling af moderat til svær aktiv Crohns sygdom hos voksne patienter, som på trods af et fuldt og adækvat behandlingsforløb med glukokortikoid og/eller immunsuppressivum ikke har responderet tilfredsstillende, eller som er intolerante over for eller har kontraindikationer mod sådanne behandlinger.
English: ≥ 40 kg
Danish: 15 kg til < 30 kg ≥ 30 kg
English: Package leaflet: Information for the patient Cyltezo 40 mg solution for injection in pre-filled pen Adalimumab
Danish: Indlægsseddel: Information til patienten Cyltezo 40 mg injektionsvæske, opløsning i fyldt pen Adalimumab
English: Cyltezo is administered via subcutaneous injection.
Danish: Cyltezo administeres ved subkutan injektion.
English: A risk for the development of hepatosplenic T-cell lymphoma in patients treated with Cyltezo cannot be excluded (see section 4.8).
Danish: En risiko for udvikling af hepatosplenisk T-celle lymfom hos patienter, der bliver behandlet med Cyltezo kan ikke
English: Cyltezo 40 mg solution for injection in pre-filled pen Cyltezo 40 mg solution for injection in single-use pre-filled pen for patient use containing a pre-filled syringe.
Danish: Cyltezo 40 mg injektionsvæske, opløsning i fyldt pen Cyltezo 40 mg injektionsvæske, opløsning i fyldt pen til engangsbrug indeholdende en fyldt injektionssprøjte, til anvendelse for patienter.
English: In adult patients with hidradenitis suppurativa, a dose of 160 mg adalimumab on week 0 followed by 80 mg on week 2 achieved serum adalimumab trough concentrations of approximately 7 to 8 µg/mL at week 2 and week 4.
Danish: Hos voksne patienter med hidrosadenitis suppurativa blev der med en dosis på 160 mg adalimumab i uge 0 efterfulgt af 80 mg ved uge 2 opnået dal-serumkoncentrationer af adalimumab på ca. 7 til 8 μg/ml ved uge 2 og uge 4.
English: Cyltezo is administered by subcutaneous injection.
Danish: Cyltezo administreres som subkutan injektion.
English: The recommended dose of Cyltezo for paediatric patients with uveitis from 2 years of age is based on body weight (Table 5).
Danish: Den anbefalede Cyltezo-dosis til pædiatriske patienter med uveitis fra 2 år er baseret på legemsvægt (tabel 5).
English: It is recommended that the patient should use a topical antiseptic wash on their HS lesions on a daily basis
Danish: Det anbefales, at patienten vasker sine HS-læsioner dagligt med et topikalt antiseptisk middel under
English: Children, adolescents and adults from 6 years of age weighing 30 kg or more The recommended dose of Cyltezo is 40 mg every other week.
Danish: Børn, unge og voksne fra 6 år, der vejer 30 kg eller mere Den anbefalede dosis Cyltezo er 40 mg hver anden uge.
English: The mean steady-state trough concentration at week 12 through week 36 were approximately 8 to 10 µg/mL during adalimumab 40 mg every week treatment.
Danish: Den gennemsnitlige dal-koncentration ved steady state var ca. 8 til 10 μg/ml under behandling med adalimumab 40 mg hver uge fra uge 12 frem til og med uge 36.
English: Children, adolescents and adults from 2 years of age weighing 30 kg or more The recommended dose of Cyltezo is 40 mg every other week.
Danish: Børn, unge og voksne fra 2 år der vejer 30 kg eller mere Den anbefalede dosis Cyltezo er 40 mg hver anden uge.
English: Erosion score 3.7 (2.7-4.7) 1.7 (1.0-2.4) 0.8 (0.4-1.2)
Danish: Placebo (N = 28) b 43,3 % (13/30) 71,4 % (20/28)
English: The safety and efficacy of adalimumab were also studied in adult patients with moderate to severe chronic plaque psoriasis with concomitant hand and/or foot psoriasis who were candidates for systemic therapy in a randomised double-blind study (Psoriasis Study III).
Danish: Adalimumabs sikkerhed og virkning er også blevet undersøgt i et randomiseret dobbeltblindet studie (Psoriasis-studie III) med voksne patienter med moderat til svær kronisk plaque-psoriasis og samtidig psoriasis på hænder og/eller fødder, som var kandidater til systemisk behandling.
English: 10, 20 and 25 mg
Danish: Minimums-, median- og maksimumsdosis 10, 20 og 25 mg 20, 25 og 40 mg
English: Some patients who experience decrease in their response to Cyltezo 40 mg every other week may benefit from an increase in dosage to 40 mg Cyltezo every week or 80 mg every other week.
Danish: Nogle patienter, som oplever, at deres respons på Cyltezo 40 mg hver anden uge bliver dårligere, kan have fordel af at øge dosis til 40 mg Cyltezo hver uge eller 80 mg hver anden uge.
English: Low Dose 20/10 mg eow N = 95
Danish: Lavdosis 20/10 mg hver anden uge N = 95
English: Adalimumab significantly delayed the time to treatment failure, as compared to placebo (See Figure 3, P < 0.0001 from log rank test).The median time to treatment failure was 24.1 weeks for subjects treated with placebo, whereas the median time to treatment failure was not estimable for subjects treated with adalimumab because less than one-half of these subjects experienced treatment failure.
Danish: Mediantiden til behandlingssvigt var 24,1 uge for patienter behandlet med placebo mens mediantiden til behandlingssvigt hos patienter behandlet med adalimumab ikke var målbar, da mindre end halvdelen af disse patienter oplevede behandlingssvigt.
English: Continued therapy beyond 16 weeks should be carefully reconsidered in a patient not responding within this
Danish: Behandling ud over 16 uger bør overvejes nøje, hvis patienten ikke responderer inden for denne
English: Note: P = Placebo (Number at Risk (flared)); A = adalimumab (Number at Risk (flared)).
Danish: Bemærk: P = Placebo (Antal med risiko (opblussen af sygdom)); A = adalimumab (Antal med risiko
English: Adalimumab 40 mg eow N = 814 n (%)
Danish: Adalimumab 40 mg hver anden uge N = 814 n (%)
English: In these trials, 11.9 % of patients treated with adalimumab and 8.1 % of placebo and active control-treated patients that had negative baseline anti-nuclear antibody titres reported positive titres at week 24.
Danish: Patienter fik testet serumprøver for autoantistoffer på forskellige tidspunkter i reumatoid artritstudier I-V. I disse havde 11,9 % af de adalimumab-behandlede patienter og 8,1 % af de placebo- og aktiv kontrolbehandlede patienter med negative antinukleære antistoftitere ved baseline positive titere efter 24 uger.
English: Chest pain, oedema, pyrexia
Danish: Brystsmerter, ødem, pyreksi
English: • Discard Cyltezo pre-filled syringe into “sharps” container.
Danish: • Bortskaf Cyltezo injektionssprøjten i beholderen til ”kanyleaffald”.
English: If these medicines do not work well enough, you will be given Cyltezo to reduce the signs and
Danish: Hvis disse lægemidler ikke virker godt nok, kan du få Cyltezo for at mindske
English: • Adults with non-infectious uveitis with inflammation affecting the back of the eye • Children from 2 years of age with chronic non-infectious uveitis with inflammation affecting the
Danish: • Voksne med ikke-infektiøs uveitis (regnbuehindebetændelse), som påvirker den bagerste del
English: Maintenance of Clinical Remission and Response (Percent of Patients) Placebo
Danish: Vedligeholdelse af klinisk remission og respons (Procentdel af patienterne)
English: If a faster effect is required your doctor may prescribe an initial dose of 160 mg (as four 40 mg injections in one day or two 40 mg injections per day for two consecutive days), followed by 80 mg (as two 40 mg injections in one day) two weeks later, and thereafter as 40 mg every other week.
Danish: Hvis en hurtigere virkning er nødvendig, kan din læge ordinere en startdosis på 160 mg (som fire 40 mg injektioner på en dag eller 2 40 mg injektioner pr. dag i to på hinanden følgende dage), efterfulgt af 80 mg (som to 40 mg injektioner på en dag) 2 uger senere, og derefter 40 mg hver anden uge.
English: Cyltezo can slow down the damage to the cartilage and bone of the joints caused by the disease and improve
Danish: Cyltezo kan nedsætte hastigheden for ødelæggelse af brusk og knogler i leddene forårsaget af sygdommen og forbedre den fysiske funktion.
English: P value
Danish: p-værdi
English: p value
Danish: P-værdi
English: Following the administration of 24 mg/m² (up to a maximum of 40 mg) subcutaneously every other week to patients with enthesitis-related arthritis who were 6 to 17 years, the mean trough steady-state (values measured at week 24) serum adalimumab concentrations were 8.8 ± 6.6 μg/mL for adalimumab without concomitant methotrexate and 11.8 ± 4.3 μg/mL with concomitant methotrexate.
Danish: 2 (op til maksimalt 40 mg) subkutant hver anden uge til patienter med entesopatirelateret artrit i alderen 6 til 17 år var den gennemsnitlige dal-serumkoncentration af adalimumab ved steady state (målt i uge 24) 8,8 ± 6,6 µg/ml uden samtidig methotrexat og 11,8 ± 4,3 µg/ml med samtidig methotrexat.
English: The usual dose regimen for Crohn's disease is 80 mg (as two 40 mg injections in one day) initially followed by 40 mg every other week starting two weeks later.
Danish: Den sædvanlige startdosis for Crohns sygdom er 80 mg (som to 40 mg injektioner på en dag) efterfulgt af 40 mg hver anden uge, der begynder 2 uger senere.
English: In monotherapy, some patients who experience a decrease in their response to Cyltezo 40 mg every other week may benefit from an increase in dosage to 40 mg adalimumab every week or 80 mg every other week.
Danish: Ved monoterapi kan det være en fordel for visse patienter, der oplever faldende respons på Cyltezo 40 mg hver anden uge, at øge dosis til 40 mg adalimumab hver uge eller 80 mg hver anden uge.
English: Cyltezo 40 mg solution for injection (injection) in pre-filled pen is supplied as a sterile 0.8 mL clear to slightly opalescent solution of 40 mg adalimumab.
Danish: Cyltezo 40 mg injektionsvæske, opløsning (injektion) i fyldt pen leveres som en steril 0,8 ml klar til let uigennemsigtig opløsning med 40 mg adalimumab.
English: • signs and symptoms suggestive of blood disorders such as persistent fever, bruising, bleeding, paleness.
Danish: • en bule eller åbent sår, som ikke vil hele • tegn og symptomer, som kan tyde på blodsygdomme så som vedvarende feber, blå mærker,
English: Intestinal perforation
Danish: Induktionsdosering
English: The recommended dose of Cyltezo for patients with enthesitis-related arthritis from 6 years of age is based on body weight (Table 2).
Danish: Den anbefalede Cyltezo-dosis til patienter fra 6 år med entesopatirelateret artrit er baseret på legemsvægt (tabel 2).
English: The usual dose for adults with non-infectious uveitis is an initial dose of 80 mg (as two injections in one day), followed by 40 mg given every other week starting one week after the initial dose.
Danish: Den sædvanlige dosis for voksne med ikke-infektiøs uveitis er en startdosis på 80 mg (som to injektioner på en dag) efterfulgt af 40 mg hver anden uge med start en uge efter den første dosis.
English: Adalimumab 40 mg eow N = 108 n (%)
Danish: Adalimumab 40 mg hver anden uge N = 108 n (%)
English: Cyltezo is only available as 40 mg pre-filled syringe/pre-filled pen.
Danish: Cyltezo fås kun som 40 mg fyldt injektionssprøjte/fyldt pen.
English: There is no relevant use of adalimumab in patients aged less than 2 years for this indication.
Danish: Det er ikke relevant at anvende adalimumab til patienter i alderen under 2 år til denne indikation.
English: • Gently remove cap by pulling it straight off. Do not touch needle or let needle touch anything.
Danish: Kanylen må ikke berøres, og den må ikke røre
English: Keep this
Danish: Tryk og hold
English: Adalimumab treated patients showed statistically significant improvements at week 26 compared with
Danish: I DLQI viste patienter behandlet med adalimumab statistisk signifikant forbedring
English: Ankylosing spondylitis and axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
Danish: Ankyloserende spondylitis og aksial spondyloartritis uden radiografiske tegn på ankyloserende
English: Cyltezo 40 mg solution for injection (injection) in pre-filled syringe is supplied as a sterile 0.8 mL clear to slightly opalescent solution of 40 mg adalimumab.
Danish: Cyltezo 40 mg injektionsvæske, opløsning (injektion) i fyldt injektionssprøjte leveres som en steril 0,8 ml klar til let uigennemsigtig opløsning med 40 mg adalimumab.
English: The Cyltezo pre-filled syringe is a single-use syringe that delivers a pre-set dose of medication.
Danish: Cyltezo fyldt injektionssprøjte er en injektionssprøjte til engangsbrug, der leverer en forudindstillet
English: Package leaflet: Information for the patient Cyltezo 40 mg solution for injection in pre-filled syringe Adalimumab
Danish: Indlægsseddel: Information til patienten Cyltezo 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte Adalimumab
English: Idiopathic thrombocytopenic purpura
Danish: Leukocytose, trombocytopeni Ikke almindelig Idiopatisk trombocytopenisk purpura Pancytopeni
English: Boehringer Ingelheim Pharma GmbH & Co. KG
Danish: Boehringer Ingelheim Pharma GmbH & Co.
English: A loading dose of 160 mg adalimumab on week 0 followed by 80 mg adalimumab on week 2 achieves serum adalimumab trough concentrations of approximately 12 μg/mL during the induction period.
Danish: Ved en induktionsdosis på 160 mg adalimumab i uge 0 efterfulgt af 80 mg adalimumab i uge 2 blev der opnået dal-serumkoncentrationer af adalimumab på ca. 12 µg/ml i induktionsperioden.
English: It is important that you tell your doctor if you have symptoms of infections, e.g. fever, wounds, feeling tired, dental
Danish: Det er vigtigt, at du informerer lægen, hvis du har symptomer på infektioner, f.eks. feber, sår, træthedsfornemmelse, tandproblemer.
English: Very common
Danish: Sjælden
English: Continued therapy beyond 16 weeks should be carefully considered in a patient not responding within this time period.
Danish: Behandling ud over 16 uger skal nøje overvejes hos patienter, som ikke responderer inden for denne
English: In adult patients with uveitis, a loading dose of 80 mg adalimumab on week 0 followed by 40 mg adalimumab every other week starting at week 1, resulted in mean steady-state concentrations of
Danish: Hos voksne patienter med uveitis resulterede en startdosis på 80 mg adalimumab i uge 0 efterfulgt af 40 mg adalimumab hver anden uge fra uge 1 i en gennemsnitskoncentration på ca. 8-10 µg/ml ved
English: In patients with ulcerative colitis, a loading dose of 160 mg adalimumab on week 0 followed by 80 mg adalimumab on week 2 achieves serum adalimumab trough concentrations of approximately 12 μg/mL during the induction period.
Danish: Hos patienter med colitis ulcerosa blev der med en induktionsdosis på 160 mg adalimumab i uge 0 efterfulgt af 80 mg adalimumab i uge 2 opnået dal-serumkoncentrationer af adalimumab på ca. 12 µg/ml i induktionsperioden.
English: • sensation of heart beating rapidly;
Danish: • fornemmelse af uregelmæssige hjerteslag såsom oversprungne slag
English: In controlled Phase 3 trials of adalimumab in patients with plaque Psoriasis with a control period duration ranging from 12 to 24 weeks, ALT elevations ≥ 3 x ULN occurred in 1.8 % of adalimumab-treated patients
Danish: I kontrollerede fase 3-studier af adalimumab hos patienter med plaque-psoriasis med en kontrolperiode på 12 til 24 uger forekom ALAT-stigninger ≥ 3 x ULN hos 1,8 % af de adalimumab-behandlede patienter og hos 1,8 % af de kontrol-behandlede patienter.
English: The other ingredients are sodium acetate trihydrate, glacial acetic acid, trehalose dihydrate, polysorbate 80
Danish: Øvrige indholdsstoffer: natriumacetattrihydrat, koncentreret eddikesyre, trehalosedihydrat, polysorbat 80 og vand til injektionsvæsker.
English: Tachycardia
Danish: Psoriasis
English: The recommended dose of Cyltezo for adult patients with uveitis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose.
Danish: Den anbefalede Cyltezo-dosis til voksne patienter med uveitis er en startdosis på 80 mg efterfulgt af 40 mg hveranden uge med start en uge efter den første dosis.
English: Cyltezo 40 mg solution for injection in pre-filled syringe Each 0.8 mL single dose pre-filled syringe contains 40 mg of adalimumab.
Danish: Cyltezo 40 mg injektionsvæske, opløsning i fyldt pen Hver fyldt 0,8 ml enkeltdosispen indeholder 40 mg adalimumab.
English: Adalimumab n = 113
Danish: Adalim umab N = 113
English: Cyltezo is used to treat psoriatic arthritis in adults.
Danish: Cyltezo bruges til at behandle psoriasisartrit hos voksne.
English: Do not twist cap. Twisting cap could damage needle.
Danish: Hvis hætten vrides, kan det beskadige kanylen.
English: SCS Boehringer Ingelheim Comm.V
Danish: Boehringer Ingelheim b.v.
English: Paediatric Plaque Psoriasis Efficacy Results at 16 Weeks
Danish: Virkningsresultater ved uge 16 for pædiatrisk plaque-psoriasis
English: The recommended Cyltezo induction dose regimen for adult patients with moderate to severe ulcerative colitis is 160 mg at week 0 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days) and 80 mg at week 2 (given as two 40 mg injections in one day).
Danish: Det anbefalede Cyltezo induktions-dosisregime til voksne patienter med moderat til svær colitis ulcerosa er 160 mg i uge 0 (givet som fire 40 mg injektioner på en dag eller som to 40 mg injektioner pr. dag i to på hinanden følgende dage) og 80 mg i uge 2 (givet som to 40 mg injektioner på en dag).
English: The recommended Cyltezo dose regimen for adult patients with hidradenitis suppurativa (HS) is 160 mg initially at Day 1 (given as four 40 mg injections in one day or as two 40 mg injections per day for two consecutive days), followed by 80 mg two weeks later at Day 15 (given as two 40 mg injections in one day).
Danish: Det anbefalede Cyltezo dosisregime til voksne patienter med hidrosadenitis suppurativa (HS) er 160 mg på dag 1 (givet som fire injektioner af 40 mg på en dag eller som to injektioner af 40 mg pr. dag i to på hinanden følgende dage), efterfulgt af 80 mg to uger senere på dag 15 (givet som to injektioner af 40 mg på en dag).
English: The usual dose for adults with psoriasis is an initial dose of 80 mg (as two 40 mg injections in one day), followed by 40 mg given every other week starting one week after the initial dose.
Danish: Den sædvanlige dosis til voksne med psoriasis er en startdosis på 80 mg (som to 40 mg injektioner på samme dag), efterfulgt af 40 mg hver anden uge startende en uge efter den første dosis.
English: Anaphylaxis
Danish: tromboflebit